Ketoconazole ophthalmic preparations containing trans-ethosomal drug nanoparticles

An ophthalmic formulation comprising transethosomes is provided. The transethosomes include a phospholipid, an edge activator, ethanol, and ketoconazole, wherein a surface of the transethosome is modified with a cationic charge inducing agent. The transethosomes may be incorporated into in situ gell...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Alhakamy, Nabil A, Alzahrani, Maram M, Ahmed, Tarek A, Felimban, Raed I
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Alhakamy, Nabil A
Alzahrani, Maram M
Ahmed, Tarek A
Felimban, Raed I
description An ophthalmic formulation comprising transethosomes is provided. The transethosomes include a phospholipid, an edge activator, ethanol, and ketoconazole, wherein a surface of the transethosome is modified with a cationic charge inducing agent. The transethosomes may be incorporated into in situ gelling or hydrogel compositions. The formulations are useful for the sustained delivery of ketoconazole to the posterior eye segment of a subject.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US11285148B1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US11285148B1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US11285148B13</originalsourceid><addsrcrecordid>eNqNyjsOwjAMANAsDAi4gzlAh_CROheBkNj4zJUVTBMptaPYLJyeDhyA6S1v7q4XMgnC-JFMICVaxDymAKVSwYqWhBWmYJg48QBWkbUhi6IyYoZnfQ_AyDJtSyGTLt3shVlp9XPh1qfj_XBuqEhPWjAQk_WPm_ebdu93bee3_5wv5o05xg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Ketoconazole ophthalmic preparations containing trans-ethosomal drug nanoparticles</title><source>esp@cenet</source><creator>Alhakamy, Nabil A ; Alzahrani, Maram M ; Ahmed, Tarek A ; Felimban, Raed I</creator><creatorcontrib>Alhakamy, Nabil A ; Alzahrani, Maram M ; Ahmed, Tarek A ; Felimban, Raed I</creatorcontrib><description>An ophthalmic formulation comprising transethosomes is provided. The transethosomes include a phospholipid, an edge activator, ethanol, and ketoconazole, wherein a surface of the transethosome is modified with a cationic charge inducing agent. The transethosomes may be incorporated into in situ gelling or hydrogel compositions. The formulations are useful for the sustained delivery of ketoconazole to the posterior eye segment of a subject.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220329&amp;DB=EPODOC&amp;CC=US&amp;NR=11285148B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220329&amp;DB=EPODOC&amp;CC=US&amp;NR=11285148B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Alhakamy, Nabil A</creatorcontrib><creatorcontrib>Alzahrani, Maram M</creatorcontrib><creatorcontrib>Ahmed, Tarek A</creatorcontrib><creatorcontrib>Felimban, Raed I</creatorcontrib><title>Ketoconazole ophthalmic preparations containing trans-ethosomal drug nanoparticles</title><description>An ophthalmic formulation comprising transethosomes is provided. The transethosomes include a phospholipid, an edge activator, ethanol, and ketoconazole, wherein a surface of the transethosome is modified with a cationic charge inducing agent. The transethosomes may be incorporated into in situ gelling or hydrogel compositions. The formulations are useful for the sustained delivery of ketoconazole to the posterior eye segment of a subject.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyjsOwjAMANAsDAi4gzlAh_CROheBkNj4zJUVTBMptaPYLJyeDhyA6S1v7q4XMgnC-JFMICVaxDymAKVSwYqWhBWmYJg48QBWkbUhi6IyYoZnfQ_AyDJtSyGTLt3shVlp9XPh1qfj_XBuqEhPWjAQk_WPm_ebdu93bee3_5wv5o05xg</recordid><startdate>20220329</startdate><enddate>20220329</enddate><creator>Alhakamy, Nabil A</creator><creator>Alzahrani, Maram M</creator><creator>Ahmed, Tarek A</creator><creator>Felimban, Raed I</creator><scope>EVB</scope></search><sort><creationdate>20220329</creationdate><title>Ketoconazole ophthalmic preparations containing trans-ethosomal drug nanoparticles</title><author>Alhakamy, Nabil A ; Alzahrani, Maram M ; Ahmed, Tarek A ; Felimban, Raed I</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US11285148B13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2022</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>Alhakamy, Nabil A</creatorcontrib><creatorcontrib>Alzahrani, Maram M</creatorcontrib><creatorcontrib>Ahmed, Tarek A</creatorcontrib><creatorcontrib>Felimban, Raed I</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Alhakamy, Nabil A</au><au>Alzahrani, Maram M</au><au>Ahmed, Tarek A</au><au>Felimban, Raed I</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Ketoconazole ophthalmic preparations containing trans-ethosomal drug nanoparticles</title><date>2022-03-29</date><risdate>2022</risdate><abstract>An ophthalmic formulation comprising transethosomes is provided. The transethosomes include a phospholipid, an edge activator, ethanol, and ketoconazole, wherein a surface of the transethosome is modified with a cationic charge inducing agent. The transethosomes may be incorporated into in situ gelling or hydrogel compositions. The formulations are useful for the sustained delivery of ketoconazole to the posterior eye segment of a subject.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US11285148B1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Ketoconazole ophthalmic preparations containing trans-ethosomal drug nanoparticles
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T16%3A34%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Alhakamy,%20Nabil%20A&rft.date=2022-03-29&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS11285148B1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true